Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0EY1K
|
||||
Former ID |
DIB011608
|
||||
Drug Name |
CB1 antagonists
|
||||
Synonyms |
CB1 antagonists (endocrine/neurological diseases); CB1 antagonists (endocrine disease), Schering-Plough; CB1 antagonists (neurological disease), Schering-Plough; CB1 antagonists (endocrine/neurological diseases), Merck & Co
|
||||
Indication | Endocrine disease [ICD10:E00-E35] | Investigative | [552035] | ||
Company |
Schering-Plough Corp
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
[C@@H]1([C@@H](CC[C@@]2(C1[C@H](NC2=O)C)CC)c1cc(cc(c1)C<br />l)OCCO)c1ccc(cc1)Cl
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Antagonist | [543877] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.